271 related articles for article (PubMed ID: 17996417)
21. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
Paterson DL; Ko WC; Von Gottberg A; Mohapatra S; Casellas JM; Goossens H; Mulazimoglu L; Trenholme G; Klugman KP; Bonomo RA; Rice LB; Wagener MM; McCormack JG; Yu VL
Clin Infect Dis; 2004 Jul; 39(1):31-7. PubMed ID: 15206050
[TBL] [Abstract][Full Text] [Related]
22. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
[TBL] [Abstract][Full Text] [Related]
23. Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene.
Lee YH; Cho B; Bae IK; Chang CL; Jeong SH
J Antimicrob Chemother; 2006 Jun; 57(6):1259-61. PubMed ID: 16595640
[No Abstract] [Full Text] [Related]
24. Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
Del Bono V; Giacobbe DR; Marchese A; Parisini A; Fucile C; Coppo E; Marini V; Arena A; Molin A; Martelli A; Gratarola A; Viscoli C; Pelosi P; Mattioli F
Virulence; 2017 Jan; 8(1):66-73. PubMed ID: 27430122
[TBL] [Abstract][Full Text] [Related]
25. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
26. A VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Weile J; Ohler S; Schönthal S; Knabbe C
Int J Antimicrob Agents; 2009 Apr; 33(4):389-91. PubMed ID: 19108993
[No Abstract] [Full Text] [Related]
27. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
Mendonça N; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Ku YH; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
[TBL] [Abstract][Full Text] [Related]
29. [Extended spectrum beta-lactamase types in Klebsiella pneumoniae strains isolated from blood cultures].
Ermertcan S; Limoncu MH; Taşli H
Mikrobiyol Bul; 2008 Jan; 42(1):9-15. PubMed ID: 18444558
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae isolate in Denmark.
Hasman H; Fjeldsøe-Nielsen H; Lausten T; Berthelsen BG
Int J Antimicrob Agents; 2010 Nov; 36(5):468-9. PubMed ID: 20724117
[No Abstract] [Full Text] [Related]
31. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
32. Panresistance in VIM-1-producing Klebsiella pneumoniae.
Miriagou V; Tzelepi E; Daikos GL; Tassios PT; Tzouvelekis LS
J Antimicrob Chemother; 2005 May; 55(5):810-1. PubMed ID: 15772141
[No Abstract] [Full Text] [Related]
33. SHV-28, an extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae in south India.
Jemima SA; Verghese S
Indian J Med Microbiol; 2009; 27(1):51-4. PubMed ID: 19172061
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.
Chien JM; Koh TH; Chan KS; Chuah TH; Tan TT
Scand J Infect Dis; 2012 Apr; 44(4):312-4. PubMed ID: 22126430
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
36. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Lee CH; Su LH; Tang YF; Liu JW
J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
[TBL] [Abstract][Full Text] [Related]
37. Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Huttner B; Pittet D; Harbarth S
J Antimicrob Chemother; 2008 Nov; 62(5):1165; author reply 1165-6. PubMed ID: 18658195
[No Abstract] [Full Text] [Related]
38. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
[TBL] [Abstract][Full Text] [Related]
39. Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
Mazzariol A; Roelofsen E; Koncan R; Voss A; Cornaglia G
Antimicrob Agents Chemother; 2007 Mar; 51(3):1082-4. PubMed ID: 17178800
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
